FindTrial
Sign In

Vasculogenic mimicry and its clinical significance in high-grade meningioma

Vasculogenic mimicry and its clinical significance in high-grade meningioma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-16009076
Enrollment
Unknown
Registered
2016-08-24
Start date
2015-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High-grade meningioma

Interventions

Case series:NA

Sponsors

Zhujiang Hospital,Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
11 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Tumor sections were reviewed by two neuropathologists to confirm diagnosis of grade II or grade III meningioma by WHO 2007 standards; 2. Patients had not undergone biopsy before surgery and the diagnosis was primary meningioma; and 3. Patients had not received radiotherapy or chemotherapy.

Exclusion criteria

Exclusion criteria: 1. Patients had undergone biopsy before surgery; 2. Patients had received rediotherapy or/and chemotherapy before surgery

Design outcomes

Primary

MeasureTime frame
Vasculogenic mimicry;Relaspe-free survival;—

Countries

China

Contacts

Public ContactYiquan Ke

Zhujiang Hospital, Southern Medical University

net_chn@hotmail.com+86 020 61643266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026